Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

A Blood Test to Prognosticate Progression-Free and Overall Survival in Cancer Patients


Technology Benefits

The benefits of this invention include high sensitivity (very low false negatives); minimally invasive as only blood samples are required; high specificity (no false positives); can be part of a broader panel of markers; can be utilized as a marker for all solid tumors, given the biology and fundamental role in metastasis.


Technology Application

Detection of these markers bears prognostic significance; and testing blood of patients could be done before, during and after chemotherapy in order to monitor patient response.


Detailed Technology Description

This invention teaches a method of evaluating cancer progression and dissemination by monitoring a specific biomarker alone or in combination with other biomarkers. The inventor has determined that detection of specific tumor cell biomarkers is a valuable method of determining cancer progression in patients.


Others

Intellectual Property Info

A patent application has been filed.


Tech ID/UC Case

23335/2013-244-0


Related Cases

2013-244-0


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View